Handelsbanken Fonder AB - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,380
-50.3%
1,000,0000.0%0.01%
-50.0%
Q2 2023$4,790
+5.6%
1,000,000
+25.0%
0.03%0.0%
Q1 2023$4,536
-98.2%
800,000
+2091.8%
0.03%
+2500.0%
Q3 2021$254,000
-33.5%
36,500
+128.1%
0.00%
-50.0%
Q2 2021$382,000
+32.6%
16,000
+14.3%
0.00%0.0%
Q1 2021$288,00014,0000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$110,730,6464.94%
Lion Point Capital, LP 691,803$3,313,7361.50%
Eversept Partners, LP 3,076,756$14,737,6611.23%
Soleus Capital Management, L.P. 2,045,983$9,800,2591.09%
Knott David M Jr 470,000$2,2510.90%
GREAT POINT PARTNERS LLC 938,067$4,493,3410.88%
Simplify Asset Management Inc. 550,626$2,637,4990.35%
Delphia (USA) Inc. 33,913$162,4430.26%
Alpha DNA Investment Management LLC 138,536$663,5870.22%
Avoro Capital Advisors LLC 2,500,000$11,975,0000.16%
View complete list of SERES THERAPEUTICS INC shareholders